Bodin F - Search Results

1

Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study.

Chin KM, Badesch DB, Robbins IM, Tapson VF, Palevsky HI, Kim NH, Kawut SM, Frost A, Benton WW, Lemarie JC, Bodin F, Rubin LJ, McLaughlin V. Chin KM, et al. Among authors: bodin f. Am Heart J. 2014 Feb;167(2):218-225.e1. doi: 10.1016/j.ahj.2013.08.008. Epub 2013 Oct 16. Am Heart J. 2014. PMID: 24439983 Free article. Clinical Trial.

2

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.

Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainisio M, Bodin F, Rubin LJ. Channick RN, et al. Among authors: bodin f. Lancet. 2001 Oct 6;358(9288):1119-23. doi: 10.1016/S0140-6736(01)06250-X. Lancet. 2001. PMID: 11597664 Clinical Trial.

3

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study.

Channick R, Badesch DB, Tapson VF, Simonneau G, Robbins I, Frost A, Roux S, Rainisio M, Bodin F, Rubin LJ. Channick R, et al. Among authors: bodin f. J Heart Lung Transplant. 2001 Feb;20(2):262-263. doi: 10.1016/s1053-2498(00)00606-9. J Heart Lung Transplant. 2001. PMID: 11250530 No abstract available.

4

Cyclosporin increases the exposure to tezosentan, an intravenous dual endothelin receptor antagonist.

van Giersbergen PL, Bodin F, Dingemanse J. van Giersbergen PL, et al. Among authors: bodin f. Eur J Clin Pharmacol. 2002 Jul;58(4):243-5. doi: 10.1007/s00228-002-0459-0. Epub 2002 May 23. Eur J Clin Pharmacol. 2002. PMID: 12136369 Clinical Trial.

5

Influence of food intake and formulation on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist.

Dingemanse J, Bodin F, Weidekamm E, Kutz K, van Giersbergen P. Dingemanse J, et al. Among authors: bodin f. J Clin Pharmacol. 2002 Mar;42(3):283-9. doi: 10.1177/00912700222011300. J Clin Pharmacol. 2002. PMID: 11865964 Clinical Trial.

6

Influence of mild liver impairment on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist.

van Giersbergen PL, Popescu G, Bodin F, Dingemanse J. van Giersbergen PL, et al. Among authors: bodin f. J Clin Pharmacol. 2003 Jan;43(1):15-22. doi: 10.1177/0091270002239701. J Clin Pharmacol. 2003. PMID: 12520623 Clinical Trial.

7

In vivo and in vitro studies exploring the pharmacokinetic interaction between bosentan, a dual endothelin receptor antagonist, and glyburide.

van Giersbergen PL, Treiber A, Clozel M, Bodin F, Dingemanse J. van Giersbergen PL, et al. Among authors: bodin f. Clin Pharmacol Ther. 2002 Apr;71(4):253-62. doi: 10.1067/mcp.2002.122473. Clin Pharmacol Ther. 2002. PMID: 11956508 Clinical Trial.

8

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril.

Holwerda NJ, Fogari R, Angeli P, Porcellati C, Hereng C, Oddou-Stock P, Heath R, Bodin F. Holwerda NJ, et al. Among authors: bodin f. J Hypertens. 1996 Sep;14(9):1147-51. doi: 10.1097/00004872-199609000-00016. J Hypertens. 1996. PMID: 8986917 Clinical Trial.

9

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine.

Corea L, Cardoni O, Fogari R, Innocenti P, Porcellati C, Provvidenza M, Meilenbrock S, Sullivan J, Bodin F. Corea L, et al. Among authors: bodin f. Clin Pharmacol Ther. 1996 Sep;60(3):341-6. doi: 10.1016/S0009-9236(96)90061-2. Clin Pharmacol Ther. 1996. PMID: 8841157 Clinical Trial.

10

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared to hydrochlorothiazide.

Hegner G, Faust G, Freytag F, Meilenbrock S, Sullivan J, Bodin F. Hegner G, et al. Among authors: bodin f. Eur J Clin Pharmacol. 1997;52(3):173-7. doi: 10.1007/s002280050270. Eur J Clin Pharmacol. 1997. PMID: 9218922 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters